Exact Mass: 582.426

Exact Mass Matches: 582.426

Found 34 metabolites which its exact mass value is equals to given mass value 582.426, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Polidocanol

3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol

C30H62O10 (582.4343)


C - Cardiovascular system > C05 - Vasoprotectives > C05B - Antivaricose therapy > C05BB - Sclerosing agents for local injection C274 - Antineoplastic Agent > C2196 - Antimetastatic Agent C78274 - Agent Affecting Cardiovascular System

   

Hericene B

{4-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2-formyl-3-hydroxy-5-methoxyphenyl}methyl (9E)-octadec-9-enoate

C37H58O5 (582.4284)


Hericene B is found in mushrooms. Hericene B is from the edible lions mane mushroom (Hericium erinaceum). From the edible lions mane mushroom (Hericium erinaceum). Hericene B is found in mushrooms.

   

NCI60_016198

NCI60_016198

C32H58N2O7 (582.4244)


   

Hericene B

Oleic acid ester of 4(3',7'-dimethyl-2',6'-octadienyl)-2-formyl-3-hydroxyl-5-methoxylbenzyl alcohol

C37H58O5 (582.4284)


   

Alcohols, C12-14, ethoxylated

Alcohols, C12-14, ethoxylated

C30H62O10 (582.4343)


   

Alcohols, C12-18, Ethoxylated

Alcohols, C12-18, Ethoxylated

C12H25O(CH2CH2O)9H (582.4343)


   

[4-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-formyl-3-hydroxy-5-methoxyphenyl]methyl (Z)-octadec-9-enoate

[4-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-formyl-3-hydroxy-5-methoxyphenyl]methyl (Z)-octadec-9-enoate

C37H58O5 (582.4284)


   

NAGlySer 17:1/10:0

NAGlySer 17:1/10:0

C32H58N2O7 (582.4244)


   

NAGlySer 13:1/14:0

NAGlySer 13:1/14:0

C32H58N2O7 (582.4244)


   

NAGlySer 13:0/14:1

NAGlySer 13:0/14:1

C32H58N2O7 (582.4244)


   

NAGlySer 11:0/16:1

NAGlySer 11:0/16:1

C32H58N2O7 (582.4244)


   

NAGlySer 14:0/13:1

NAGlySer 14:0/13:1

C32H58N2O7 (582.4244)


   

NAGlySer 10:0/17:1

NAGlySer 10:0/17:1

C32H58N2O7 (582.4244)


   

NAGlySer 16:1/11:0

NAGlySer 16:1/11:0

C32H58N2O7 (582.4244)


   

NAGlySer 14:1/13:0

NAGlySer 14:1/13:0

C32H58N2O7 (582.4244)


   

NAGlySer 15:1/12:0

NAGlySer 15:1/12:0

C32H58N2O7 (582.4244)


   

NAGlySer 12:0/15:1

NAGlySer 12:0/15:1

C32H58N2O7 (582.4244)


   

2,3-Dihydroxypropyl (2-hydroxy-3-tetracosoxypropyl) hydrogen phosphate

2,3-Dihydroxypropyl (2-hydroxy-3-tetracosoxypropyl) hydrogen phosphate

C30H63O8P (582.426)


   

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H58O5 (582.4284)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H58O5 (582.4284)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H58O5 (582.4284)


   

(1-hydroxy-3-octanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

(1-hydroxy-3-octanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoate

C37H58O5 (582.4284)


   

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C37H58O5 (582.4284)


   

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H58O5 (582.4284)


   

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (11E,13E,15E)-octadeca-11,13,15-trienoate

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (11E,13E,15E)-octadeca-11,13,15-trienoate

C37H58O5 (582.4284)


   

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (10E,12E)-octadeca-10,12-dienoate

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (10E,12E)-octadeca-10,12-dienoate

C37H58O5 (582.4284)


   

Polidocanol

Nonaethylene glycol monododecyl ether

C30H62O10 (582.4343)


C - Cardiovascular system > C05 - Vasoprotectives > C05B - Antivaricose therapy > C05BB - Sclerosing agents for local injection C274 - Antineoplastic Agent > C2196 - Antimetastatic Agent C78274 - Agent Affecting Cardiovascular System

   

TG(34:7)

TG(12:1(1)_11:3_11:3)

C37H58O5 (582.4284)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DG 34:7

DG 34:7

C37H58O5 (582.4284)


   

LPG O-24:0

LPG O-24:0

C30H63O8P (582.426)


   

DCAE 13:3

DCAE 13:3

C37H58O5 (582.4284)


   

[4-(3,7-dimethylocta-2,6-dien-1-yl)-2-formyl-3-hydroxy-5-methoxyphenyl]methyl octadec-9-enoate

[4-(3,7-dimethylocta-2,6-dien-1-yl)-2-formyl-3-hydroxy-5-methoxyphenyl]methyl octadec-9-enoate

C37H58O5 (582.4284)


   

(6e)-3,4-dihydroxy-2-methoxy-8-methyl-n-(1-methyl-2-oxoazepan-3-yl)-5-(tetradecanoyloxy)non-6-enimidic acid

(6e)-3,4-dihydroxy-2-methoxy-8-methyl-n-(1-methyl-2-oxoazepan-3-yl)-5-(tetradecanoyloxy)non-6-enimidic acid

C32H58N2O7 (582.4244)


   

{4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-formyl-3-hydroxy-5-methoxyphenyl}methyl (9z)-octadec-9-enoate

{4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2-formyl-3-hydroxy-5-methoxyphenyl}methyl (9z)-octadec-9-enoate

C37H58O5 (582.4284)